[FG] Katan Mira

Rohner, R. et al. (2024) ‘Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized-controlled ELAN Trial’, Circulation [Preprint]. Available at: https://doi.org/10.1161/circulationaha.124.069324.

van Niftrik, Christiaan H.B. et al. (2024) ‘Increased Risk of Recurrent Stroke in Symptomatic Large Vessel Disease With Impaired BOLD Cerebrovascular Reactivity’, Stroke [Preprint]. Available at: https://doi.org/10.1161/strokeaha.123.044259.

Best, Jonathan G. et al. (2024) ‘Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA: A Pooled Analysis’, Neurology, 102. Available at: https://doi.org/10.1212/wnl.0000000000207795.

Dittrich, Tolga D et al. (2024) ‘Absent leptomeningeal collateralization is associated with greatest benefit from mechanical thrombectomy in the 6-24 hour time window’, European Stroke Journal [Preprint]. Available at: https://doi.org/10.1177/23969873241239208.

Goeldlin, Martina B. et al. (2024) ‘CADMUS: A Novel MRI-Based Classification of Spontaneous Intracerebral Hemorrhage Associated With Cerebral Small Vessel Disease’, Neurology, 102. Available at: https://doi.org/10.1212/wnl.0000000000207977.

Kaufmann, Josefin E. et al. (2024) ‘Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT-CAD Randomized Trial’, Annals of Neurology [Preprint]. Available at: https://doi.org/10.1002/ana.26886.

Kriemler, Lilian et al. (2024) ‘Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age’, European Stroke Journal, 9, pp. 494–500. Available at: https://doi.org/10.1177/23969873231221619.

Siepen, Bernhard M. et al. (2024) ‘Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries’, Stroke and Vascular Neurology [Preprint]. Available at: https://doi.org/10.1136/svn-2023-002813.

Sporns, Peter B. et al. (2024) ‘Simulation of transportation of acute stroke patients in border regions’, Scientific Reports, 14. Available at: https://doi.org/10.1038/s41598-024-51959-y.

Stefanou, Maria-Ioanna et al. (2024) ‘Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis’, European Stroke Journal, null. Available at: https://doi.org/10.1177/23969873241234238.

Zietz, A. et al. (2024) ‘Targeting inflammation to reduce recurrent stroke’, International Journal of Stroke, 19, pp. 379–387. Available at: https://doi.org/10.1177/17474930231207777.

Cameron, A. et al. (2023) ‘Natriuretic Peptides Improve Classification of People at Low Risk of Atrial Fibrillation after Stroke’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.09.28.23296282.

Schulze-Zachau V et al. (2023) ‘Incidence and outcome of perforations during medium vessel occlusion compared with large vessel occlusion thrombectomy.’, Journal of neurointerventional surgery [Preprint]. Available at: https://doi.org/10.1136/jnis-2023-020531.

Paciaroni M et al. (2023) ‘Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study.’, European stroke journal, p. 23969873231186863. Available at: https://doi.org/10.1177/23969873231186863.

Soo Y et al. (2023) ‘Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation.’, Annals of neurology, 94(1), pp. 61–74. Available at: https://doi.org/10.1002/ana.26642.

Arnold M, Kaesmacher J and Katan M (2023) ‘How to Keep Your (Stroke) Trial Alive?’, Stroke, 54(4), pp. e167–e170. Available at: https://doi.org/10.1161/strokeaha.122.037784.

Seystahl K et al. (2023) ‘Stroke-associated infections in patients with and without cancer.’, Neuro-oncology practice, 10(2), pp. 176–185. Available at: https://doi.org/10.1093/nop/npac075.

Cameron, Alan C. et al. (2023) ‘Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol’, Cerebrovascular Diseases, 52, pp. 123–129. Available at: https://doi.org/10.1159/000525918.

Dittrich, Tolga D et al. (2023) ‘Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications – the PLEURA study’, European Stroke Journal, 8, pp. 549–556. Available at: https://doi.org/10.1177/23969873231151488.

Dittrich, Tolga D et al. (2023) ‘Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients’, International Journal of Stroke, 18, pp. 697–703. Available at: https://doi.org/10.1177/17474930221140793.

Dittrich, Tolga D. et al. (2023) ‘Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study’, Stroke, 54, pp. 722–730. Available at: https://doi.org/10.1161/strokeaha.122.039793.

Honegger, Tim et al. (2023) ‘Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke’, European Stroke Journal, 8, pp. 309–319. Available at: https://doi.org/10.1177/23969873221145391.

Lyrer, Flurina et al. (2023) ‘Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation’, Annals of Neurology, 94, pp. 43–54. Available at: https://doi.org/10.1002/ana.26654.

Schütz, Valerie et al. (2023) ‘The Role of Electrocardiographic Markers for Predicting Atrial Fibrillation in Patients with Acute Ischemic Stroke: Data from the BIOSIGNAL Cohort Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12216830.

Silimon, Norbert et al. (2023) ‘Ischaemic stroke despite antiplatelet therapy: Causes and outcomes’, European Stroke Journal, 8, pp. 692–702. Available at: https://doi.org/10.1177/23969873231174942.

Sinka, Lucia et al. (2023) ‘Association of Mortality and Risk of Epilepsy with Type of Acute Symptomatic Seizure after Ischemic Stroke and an Updated Prognostic Model’, JAMA Neurology, 80, pp. 605–613. Available at: https://doi.org/10.1001/jamaneurol.2023.0611.

Ward, Kirsty et al. (2023) ‘Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review’, European Stroke Journal, 8, pp. 125–131. Available at: https://doi.org/10.1177/23969873221136927.

Thomas R Meinel et al. (2023) ‘Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants’, JAMA Neurology [Preprint].

Seiffge DJ et al. (2022) ‘Cerebral Amyloid Angiopathy and the Risk of Hematoma Expansion.’, Annals of neurology, 92(6), pp. 921–930. Available at: https://doi.org/10.1002/ana.26481.

De Marchis GM et al. (2022) ‘Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.’, Atherosclerosis, 361, pp. 41–46. Available at: https://doi.org/10.1016/j.atherosclerosis.2022.09.007.

Altersberger VL et al. (2022) ‘Thrombolysis in stroke patients with elevated inflammatory markers.’, Journal of neurology, 269(10), pp. 5405–5419. Available at: https://doi.org/10.1007/s00415-022-11173-0.

Inauen C. et al. (2022) ‘Blood Pressure Variability Indices for Outcome Prediction After Thrombectomy in Stroke by Using High-Resolution Data’, Neurocritical Care, 37, pp. 220–229. Available at: https://doi.org/10.1007/s12028-022-01519-x.

Paciaroni M et al. (2022) ‘Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.’, Stroke, 53(8), pp. 2620–2627. Available at: https://doi.org/10.1161/strokeaha.121.038239.

Bicvic A et al. (2022) ‘A novel biomarker panel index improves risk stratification after ischemic stroke’, European Stroke Journal, 7(2), pp. 158–165. Available at: https://doi.org/10.1177/23969873221090798.

Polymeris AA et al. (2022) ‘Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation.’, Journal of neurology, neurosurgery, and psychiatry, 93(6), pp. 588–598. Available at: https://doi.org/10.1136/jnnp-2021-328391.

Wagner B et al. (2022) ‘Endovascular Treatment for Acute Ischemic Stroke With or Without General Anesthesia: A Matched Comparison.’, Stroke, 53(5), pp. 1520–1529. Available at: https://doi.org/10.1161/strokeaha.121.034934.

Schweizer J et al. (2022) ‘Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.’, Journal of the American College of Cardiology, 79(14), pp. 1369–1381. Available at: https://doi.org/10.1016/j.jacc.2022.01.042.

Bicciato G. et al. (2022) ‘Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion’, Current Opinion in Neurology, 35(1), pp. 45–54. Available at: https://doi.org/10.1097/wco.0000000000001011.

Du Fay De Lavallaz, Jeanne et al. (2022) ‘Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T’, Circulation, 145, pp. 1764–1779. Available at: https://doi.org/10.1161/circulationaha.121.058489.

Kimura, Shunsuke et al. (2022) ‘Practical ‘1-2-3-4-Day’ Rule for Starting Direct Oral Anticoagulants after Ischemic Stroke with Atrial Fibrillation: Combined Hospital-Based Cohort Study’, Stroke, 53, pp. 1540–1549. Available at: https://doi.org/10.1161/strokeaha.121.036695.

Liberale, Luca et al. (2022) ‘Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke’, Scientific Reports, 12. Available at: https://doi.org/10.1038/s41598-022-23211-y.

Alan C Camero et al. (2022) ‘Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol’, Cerebrovascular Diseases. 29.08.2022, p. 7. Available at: https://doi.org/10.1159/000525918.

Katharina Seystahl et al. (2022) ‘Stroke-associated infections in patients with and without cancer’, Neuro-Oncology Practice [Preprint]. 25.09.2022. Available at: https://doi.org/10.1093/nop/npac075.

Kirsty Ward et al. (2022) ‘Molecular biomarkers predicting newly detected atrial fibrillation after ischemic stroke or TIA: A systematic review’, European Stroke Journal [Preprint]. 18.10.2022. Available at: https://doi.org/10.1177/23969873221136927.

Luca Liberale et al. (2022) ‘Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke’, Scientific Reports. 28.11.2022, 12(1), p. 8. Available at: https://www.nature.com/articles/s41598-022-23211-y.

S Ministrini et al. (2022) ‘Endothelial expression of JCAD worsens outcome after acute ischemic stroke: a translational study’, European Heart Journal. 02.10.2022, 32, p. 1. Available at: https://doi.org/10.1093/eurheartj/ehac544.1993.

Tolga Daniel Dittrich et al. (2022) ‘Mechanical Thrombectomy For Large Vessel Occlusion Between 6 And 24 Hours: Outcome Comparison Of Defuse-3/Dawn Eligible Versus Non-Eligible Patients’, International Journal of Stroke [Preprint]. 11.11.2022. Available at: https://doi.org/10.1177/17474930221140793.

Ferreira-Atuesta C. et al. (2021) ‘Seizures after Ischemic Stroke: A Matched Multicenter Study’, Annals of Neurology, 90(5), pp. 808–820. Available at: https://doi.org/10.1002/ana.26212.

Seystahl K. et al. (2021) ‘Cancer is associated with inferior outcome in patients with ischemic stroke’, Journal of Neurology, 268(11), pp. 4190–4202. Available at: https://doi.org/10.1007/s00415-021-10528-3.

Katan M. and Wegener S. (2021) ‘Secondary prevention of ischemic stroke: Laboratory and imaging biomarkers Sekundärprävention des Hirnschlags: Laborchemische und bildgebende Biomarker beim ischämischen Schlaganfall’, Therapeutische Umschau, 78(6), pp. 291–298. Available at: https://doi.org/10.1024/0040-5930/a001273.

Arnold M et al. (2021) ‘Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.’, European heart journal, 42(22), pp. 2186–2196. Available at: https://doi.org/10.1093/eurheartj/ehab081.

Gil L.A. et al. (2021) ‘A panel comprising serum amyloid a, white blood cells and nihss for the triage of patients at low risk of post-stroke infection’, Diagnostics, 11(6). Available at: https://doi.org/10.3390/diagnostics11061070.

Arnold M., Gill D. and Katan M. (2021) ‘A Good Start to Shed More Light on the Relationship Between Glycemic Traits, Diabetes Mellitus, and Cerebrovascular Disease’, Neurology, 96(13), pp. 602–603. Available at: https://doi.org/10.1212/wnl.0000000000011557.

Westphal L.P. et al. (2021) ‘C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke’, Frontiers in Neurology, 11. Available at: https://doi.org/10.3389/fneur.2020.629151.

Aguiar De Sousa D. and Katan M. (2021) ‘Promising Use of Automated Electronic Phenotyping: Turning Big Data Into Big Value in Stroke Research’, Stroke, 52(1), pp. 190–192. Available at: https://doi.org/10.1161/strokeaha.120.033061.

Hotter B. et al. (2021) ‘External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers’, Stroke, 52(1), pp. 325–330. Available at: https://doi.org/10.1161/strokeaha.120.031884.

Meinel T.R. et al. (2021) ‘Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation’, Annals of Neurology, 89(1), pp. 42–53. Available at: https://doi.org/10.1002/ana.25917.

Schweizer J. et al. (2020) ‘SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections’, Stroke, 51(12), pp. 3523–3530. Available at: https://doi.org/10.1161/strokeaha.120.030064.

Arnold M. et al. (2020) ‘Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time’, Stroke, 51(6), pp. 1873–1875. Available at: https://doi.org/10.1161/strokeaha.120.029333.

Gruber P. et al. (2020) ‘Proenkephalin A Adds No Incremental Prognostic Value After Acute Ischemic Stroke’, Clinical and Applied Thrombosis/Hemostasis, 26. Available at: https://doi.org/10.1177/1076029619895318.

Zietz, Annaelle, Sutter, Raoul and De Marchis, Gian Marco (2020) ‘Deep Vein Thrombosis and Pulmonary Embolism Among Patients With a Cryptogenic Stroke Linked to Patent Foramen Ovale-A Review of the Literature’, Frontiers in Neurology, 11, p. 336. Available at: https://doi.org/10.3389/fneur.2020.00336.

Valérie Schütz and Mira Katan (2020) ‘Ursachenabklärung des ischämischen Schlaganfalls – eine spannende Herausforderung’, LEADING OPINIONT Neurologie & Psychiatrie [Preprint]. 30.10.2020. Available at: https://www.universimed.com/at/article/neurologie/ursachenabklaerung-schlaganfalls-2272928.

Kishore A.K. et al. (2019) ‘Antibiotic treatment for pneumonia complicating stroke: Recommendations from the pneumonia in stroke consensus (PISCES) group’, European Stroke Journal, 4(4), pp. 318–328. Available at: https://doi.org/10.1177/2396987319851335.

Sandset EC et al. (2019) ‘Women in the European Stroke Organisation: One, two, many… – A Top Down and Bottom Up approach’, European Stroke Journal, 4(3), pp. 247–253. Available at: https://doi.org/10.1177/2396987319841979.

Loch Macdonald R. and Katan M. (2019) ‘Haptoglobin and hemoglobin in subarachnoid hemorrhage A tale of 2 globins’, Neurology, 92(18), pp. 831–832. Available at: https://doi.org/10.1212/wnl.0000000000007399.

Katan M. and Lubitz S.A. (2019) ‘ECG monitoring after acute ischemic stroke: Does patient selection matter?’, Neurology, 92(2), pp. 65–66. Available at: https://doi.org/10.1212/wnl.0000000000006719.

De Marchis, Gian Marco et al. (2019) ‘A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score’, Neurology, 92(13), pp. e1517–e1525. Available at: https://doi.org/10.1212/wnl.0000000000007177.

De Marchis GM et al. (2018) ‘Incorporating Biomarkers Into a Stroke Research Career’, Stroke, 49(12), pp. e329–e331. Available at: https://doi.org/10.1161/strokeaha.118.022915.

Katan M. and Luft A. (2018) ‘Global Burden of Stroke’, Seminars in Neurology, 38(2), pp. 208–211. Available at: https://doi.org/10.1055/s-0038-1649503.

De Marchis, Gian Marco et al. (2018) ‘Serum neurofilament light chain in patients with acute cerebrovascular events’, European Journal of Neurology, 25(3), pp. 562–568. Available at: https://doi.org/10.1111/ene.13554.

De Marchis, Gian Marco et al. (2018) ‘Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke’, Neurology, 90, pp. e455–e465. Available at: https://doi.org/10.1212/wnl.0000000000004922.

Wegener S. and Katan M. (2018) ‘Getting the First Grant’, Stroke, 49(1). Available at: https://doi.org/10.1161/strokeaha.117.019897.

Mira Katan and Mitchell SV Elkind (2018) ‘The potential role of blood biomarkers in patients with ischemic stroke: An expert opinion’, Clinical and Transitional Neuroscience. 09.04.2018, 2. Available at: https://doi.org/10.1177/2514183X18768050.

Hotter B. et al. (2017) ‘Selection bias in clinical stroke trials depending on ability to consent’, BMC Neurology, 17(1). Available at: https://doi.org/10.1186/s12883-017-0989-9.

Schmidt A., Katan M. and Sandset E.C. (2017) ‘Why Is It Worthwhile to Get Involved in Stroke Organizations?’, Stroke, 48(10), pp. e277–e279. Available at: https://doi.org/10.1161/strokeaha.117.018850.

Scherrer N et al. (2017) ‘Microrna 150-5p improves risk classification for mortality within 90 days after acute ischemic stroke’, Journal of Stroke, 19(3), pp. 323–332. Available at: https://doi.org/10.5853/jos.2017.00423.

Li Z. and Katan M. (2017) ‘Coming to the United States for a Stroke Research Fellowship’, Stroke, 48(8), pp. e190–e192. Available at: https://doi.org/10.1161/strokeaha.117.018084.

Azurmendi L. et al. (2017) ‘Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: A pilot study’, Clinical Proteomics, 14(1). Available at: https://doi.org/10.1186/s12014-017-9162-0.

Ulm L. et al. (2017) ‘The randomized controlled STRAWINSKI trial: Procalcitonin-guided antibiotic therapy after stroke’, Frontiers in Neurology, 8(APR). Available at: https://doi.org/10.3389/fneur.2017.00153.

Bustamante A. et al. (2017) ‘C-reactive protein in the detection of post-stroke infections: systematic review and individual participant data analysis’, Journal of Neurochemistry, 141(2), pp. 305–314. Available at: https://doi.org/10.1111/jnc.13973.

Katan M. et al. (2017) ‘Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study’, Stroke, 48(3), pp. 604–610. Available at: https://doi.org/10.1161/strokeaha.116.014945.

Blum, Claudine Angela et al. (2017) ‘Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study’, Journal of Headache and Pain, 18(1), p. 21. Available at: https://doi.org/10.1186/s10194-017-0733-2.

Kelly P.J. et al. (2016) ‘Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies’, The Lancet Neurology, 15(12), pp. 1238–1247. Available at: https://doi.org/10.1016/s1474-4422(16)30236-8.

Katan, M. et al. (2016) ‘Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study’, Stroke, 47(7), pp. 1714–9. Available at: https://doi.org/10.1161/strokeaha.115.011392.

Urwyler, Sandrine Andrea et al. (2016) ‘Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome’, The Journal of Clinical Endocrinology and Metabolism, 101(5), pp. 1917–23. Available at: https://doi.org/10.1210/jc.2016-1158.

Gutierrez J., Katan M. and Elkind M.S.V. (2015) ‘Collagen Vascular and Infectious Diseases’. Elsevier Inc., pp. 619–631. Available at: https://doi.org/10.1016/b978-0-323-29544-4.00036-0.

Timper, K. et al. (2015) ‘Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study’, Journal of Clinical Endocrinology and Metabolism, 100(6), pp. 2268–74. Available at: https://doi.org/10.1210/jc.2014-4507.

Julian Sonderer and Mira Katan Kahles (2015) ‘Aetiological blood biomarkers of ischaemic stroke’, Swiss Med Weakly. 17.05.2015, 2122(145), p. 15. Available at: https://doi.org/10.4414/smw.2015.14138.

Michael Varner, Mira Katan and Kathleen Digree (2015) ‘Epilepsy and Pregnancy’, Maternal Medicine. Mcgraw Hill Professional, 7.

Frontzek K. et al. (2014) ‘Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: A pilot study’, PLoS ONE, 9(3). Available at: https://doi.org/10.1371/journal.pone.0092421.

Katan M. et al. (2014) ‘Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: The Northern Manhattan Study’, PLoS ONE, 9(1). Available at: https://doi.org/10.1371/journal.pone.0083393.

De Marchis, G. M. et al. (2014) ‘Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study’, Stroke, 45(10), pp. 2918–23. Available at: https://doi.org/10.1161/strokeaha.114.005584.

Fischer, M. et al. (2014) ‘The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke’, Cerebrovascular Diseases, 37(2), pp. 128–133. Available at: https://doi.org/10.1159/000357215.

Nigro, N. et al. (2014) ‘BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events’, PLoS ONE, 9(7), p. e102704. Available at: https://doi.org/10.1371/journal.pone.0102704.

Senn R et al. (2014) ‘Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage’, Cerebrovascular Diseases, 38(6), pp. 395–409. Available at: https://doi.org/10.1159/000366470.

Katan M. and Elkind M.S.V. (2013) ‘Infectious burden and its role in cerebrovascular disease and cognitive impairment’, Future Virology, 8(9), pp. 833–836. Available at: https://doi.org/10.2217/fvl.13.74.

De Marchis GM et al. (2013) ‘Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study’, International Journal of Stroke, 8(3), pp. 214–218. Available at: https://doi.org/10.1111/j.1747-4949.2011.00762.x.

Katan M. et al. (2013) ‘Infectious burden and cognitive function: The Northern Manhattan Study’, Neurology, 80(13), pp. 1209–1215. Available at: https://doi.org/10.1212/wnl.0b013e3182896e79.

Fung C. et al. (2013) ‘Copeptin as a Marker for Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage’, PLoS ONE, 8(1). Available at: https://doi.org/10.1371/journal.pone.0053191.

Blum, C. A. et al. (2013) ‘Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke’, PLoS ONE, 8(5), p. e63224. Available at: https://doi.org/10.1371/journal.pone.0063224.